Skip to content

Evaluation of Post-operative Respiratory Complications After Thoracic Surgery in Patients With COPD

Evaluation of Post-operative Respiratory Complications After Thoracic Surgery in Patients With COPD

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02268708
Enrollment
100
Registered
2014-10-20
Start date
2014-07-31
Completion date
2016-02-29
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Malignant Neoplasm of Thorax

Keywords

COPD, Surgery, Thoracic

Brief summary

Evaluation of post-operative respiratory complications after thoracic surgery for pulmonary resection in patients with COPD Introduction: Postoperative pulmonary complications following pulmonary resection occur in 12-40% of cases. Some risk factors such as COPD are well identified. It has been shown that COPD patients with a history of frequent exacerbations are more likely to develop exacerbations. No study has evaluated the rate of patients called 'frequent exacerbators' among COPD patients requiring pulmonary resection and the relations between exacerbations history and incidence of acute respiratory postoperative complications. The main objective is to determine the frequency of pulmonary postoperative complications (atelectasis, acute respiratory failure, pneumonia) following lung resection in COPD patients. The secondary objectives are to determine the frequency of extra pulmonary postoperative complications and the prevalence of the 'frequent exacerbator' phenotype in this population, as well as its relation with the risk of post-operative complications. Materials and Methods: This is a prospective, observational, single-center study, of patients with COPD hospitalized for elective thoracic surgery in the center of Thoracic Surgery, Hôpital Cochin. The inclusion criteria are: male or female aged more than 40 years, permanent airflow obstruction as defined by an FEV/FVC ratio \< 70% after bronchodilator. Collected data will be: COPD symptoms (dyspnea score, exacerbations) by a questionnaire given to the patient during the anesthesia consultation, COPD severity scores, comorbidities, per operative data, postoperative complications, hospitalization and intra-hospital mortality. Perspectives: This work will provide information on the risk of postoperative complications in patients with COPD and the influence of the 'frequent exacerbator' phenotype. This will help adapting preventive care to the COPD subtype .

Interventions

PROCEDUREOncological pulmonary resection

Respiratory evaluation before sugery Oncological pulmonary resection with general anesthesia. Hospitalization for post operative care

Sponsors

Hôpital Cochin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female \>40 years old * COPD permanent airflow obstruction as defined by an FEV/FVC ratio \< 70% after bronchodilator * Hospitalized for elected surgical pulmonary resction

Exclusion criteria

* Pregnancy * Patient under Long duration Oxygen * Questionnaire information impossible to understand (because of language)

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of pulmonary postoperative complications lung resection in COPD patients.1 YEAREvaluate the prevalence of atelectasis, acute respiratory failure and post operative pneumonia after thoracic surgery for lung resection in COPD (Chronic Obstructive Pulmonary Disease) patients.

Secondary

MeasureTime frameDescription
It is to determine the prevalence of the 'frequent exacerbator' phenotype in this COPD population, as well as its relation with the risk of post-operative complications.1 YEAR
Mortality30 days
Duration of total hospitalisation, and ICU hospitalisation30 days
Any other non respiratory complication30 daysCoplications: cardiac, kiddney, sepsis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026